Skip to Main Content

Paper Details

Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling.
J Mol Diagn
12
2022
26, BRCA mutations, BRCA1, BRCA2, DNA libraries, GIS, HRD, Homologous Recombination Deficiency, Ovarian Cancer, homologous recombination deficiency, ovarian cancer, ovarian carcinoma, patient, patients, tumors
Author NameAffiliation
Stefan KommossTubingen University Hospital
Stefan KommossTubingen University Hospital
Andreas du Bois
Timo GaiserInstitute of Pathology, University Medical Centre Mannheim, University of Heidelberg
Timo GaiserInstitute of Pathology, University Medical Centre Mannheim, University of Heidelberg
  • 1 - 5

Datasets

Release 1.2